Skip to main content

Table 3 Summary of adverse drug reactions (ADRs) seen in ≥ 3% of patients (N = 148)

From: Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India

ADR

n (%)

Nausea

29 (19.6)

Headache

26 (17.6)

Diarrhoea

22 (14.9)

Dry mouth

20 (13.5)

Decreased appetite

18 (12.2)

Insomnia

16 (10.8)

Fatigue

14 (9.5)

Constipation

14 (9.5)

Dizziness

12 (8.1)

Tremors

9 (6.1)

Vomiting

9 (6.1)

Sweating

8 (5.4)

Drowsiness

8 (5.4)

Abdominal pain

6 (4.1)

Anxiety

5 (3.4)

Sexual dysfunctiona

3 (4.9)

  1. N, total study population; n, number of patients reporting ADR
  2. aPercentage is calculated out of male patients only (n = 61)